profile image
I would no longer add to Pfizer. No growth in the share.
profile image
@Irina Let's say: given the current dividend yield, $PFE might not be the worst stock to build up tax offsetting potential for the time of a "big" portfolio reorganization as soon as I am no longer subject to the trade restrictions of my employer. Of course, this does not apply to $BAYN to the same extent at the moment, but to be honest, I expect them to overcome the Monsanto debacle at some point and then resume their original position in the chemical industry. Industry again. I am patient in this respect, of necessity.